Kim Jungghi, Ha Jong-Gyun, Cho Hyung-Ju
Department of Otorhinolaryngology, Yonsei University College of Medicine, Seoul, Republic of Korea.
Airway Mucus Institute, Yonsei University College of Medicine, Seoul, Republic of Korea.
J Rhinol. 2022 Mar;29(1):56-58. doi: 10.18787/jr.2021.00386. Epub 2022 Mar 28.
Central sleep apnea (CSA) is defined as an absence of breathing without respiratory drive during sleep. It can occur after treatment of obstructive sleep apnea (OSA), a phenomenon known as treatment-emergent central sleep apnea (TECSA). We present a case of a 23-year-old male who developed CSA after pharyngeal and nasal surgery for severe OSA. High loop gain and increased ventilations from frequent arousal are likely explanations for our patient's central apnea, which resolved with positive airway pressure therapy that possibly alleviated residual airway obstruction and ventilatory instability. This case suggests that effectiveness of treatment for OSA should be based on careful long-term observation with multiple follow-up polysomnography tests, especially in patients at high risk of TECSA.
中枢性睡眠呼吸暂停(CSA)被定义为睡眠期间无呼吸驱动的呼吸停止。它可发生在阻塞性睡眠呼吸暂停(OSA)治疗后,这种现象被称为治疗后出现的中枢性睡眠呼吸暂停(TECSA)。我们报告一例23岁男性,在因严重OSA接受咽喉和鼻腔手术后发生了CSA。高环路增益以及频繁觉醒导致的通气增加可能是我们患者中枢性呼吸暂停的原因,通过气道正压治疗,该症状得到缓解,可能是因为这种治疗减轻了残余气道阻塞和通气不稳定。该病例表明,OSA治疗的有效性应基于通过多次随访多导睡眠图检查进行仔细的长期观察,尤其是对于有TECSA高风险的患者。